Changes in the permeability of the intestinal mucosa may be manifested through alterations in gastrointestinal pathology, intestinal microbes and metabolites, obstacles in IgA synthesis and secretion and endotoxemia. This evidence concerns the gene CD79A and serum lipopolysaccharide activity.